Michael Sprenger, CEO of Hapa Medical

(02.07.19)

In these four short videos Michael Sprenger, CEO of Hapa Medical discusses the potential size of the medical cannabis market in Europe, the barriers to entry for medical cannabis and how easy/difficult it is to retain intellectual property and avoid commoditised pricing. Click the image below to watch the videos.

The views in these videos are those of Michael Sprenger, CEO of Hapa Medical.

This communication is for use only by a person or entity that qualifies as a "Professional Client" or "Eligible Counterparty" within the meaning of the FCA's rules. It is therefore intended for use only by persons having professional experience in matters relating to investments. Any other person who receives this should not act on the contents. Disclaimer here

London
New York

Our offices

London

Ropemaker Place, Level 12 25 Ropemaker Street London EC2Y 9LY

New York

20th Floor 575 Fifth Avenue New York NY 10017